Last 12 months
Inside the activity.
0 purchase rows · 34 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 23, 2020 Filed Nov 24, 2020 21:09 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionCommon Stock | 15,000 | $2.76 | $41,400.00 |
DisclosureSEC source: 0001593968-20-002243 · primary_01.xml · nonDerivative · entry 2 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:09 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionCommon Stock | 15,000 | $3.74 | $56,100.00 |
DisclosureSEC source: 0001593968-20-002243 · primary_01.xml · nonDerivative · entry 1 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2020 Filed Jan 28, 2021 21:19 UTC |
Flynn Sean C.VP, General Counsel
|
GrantCommon Stock | 138 | $12.64 | $1,744.25 |
DisclosureSEC source: 0001593968-21-000237 · primary_01.xml · nonDerivative · entry 3 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,989 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 30, 2020 Filed Jan 28, 2021 21:23 UTC |
Colangelo DominickDirector · President and CEO
|
GrantCommon Stock | 610 | $7.23 | $4,412.44 |
DisclosureSEC source: 0001593968-21-000239 · primary_01.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,102 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 30, 2020 Filed Jan 28, 2021 21:19 UTC |
Flynn Sean C.VP, General Counsel
|
GrantCommon Stock | 1,042 | $7.23 | $7,537.31 |
DisclosureSEC source: 0001593968-21-000237 · primary_01.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,851 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 20:19 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 14,751 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001593968-20-001510 · primary_01.xml · derivative · entry 3 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,579 Underlying: Common Stock · 14,751 shares Expires 2028-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 40,330 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted. Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 20:19 UTC |
Halpin MichaelChief Operating Officer
|
SaleCommon Stock | 14,751 | $15.01 | $221,412.51 |
DisclosureSEC source: 0001593968-20-001510 · primary_01.xml · nonDerivative · entry 2 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,622 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2020. Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 20:19 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionCommon Stock | 14,751 | $7.20 | $106,207.20 |
DisclosureSEC source: 0001593968-20-001510 · primary_01.xml · nonDerivative · entry 1 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:03 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,890 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001593968-20-001498 · primary_01.xml · derivative · entry 4 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,063 Underlying: VCEL · 2,890 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options, representing the right to purchase 135,000 shares, became exercisable on April 10, 2018, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:03 UTC |
Halpin MichaelChief Operating Officer
|
SaleCommon Stock | 1,112 | $15.00 | $16,680.00 |
DisclosureSEC source: 0001593968-20-001498 · primary_01.xml · nonDerivative · entry 3 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,622 F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one common share of stock. F4 · shares: These disposed shares were from an award that was granted on February 6, 2019. 1,875 restricted stock units subject to the award vested on February 6, 2020, and 1,875 restricted stock units are scheduled to vest on February 6, 2021, February 6, 2022, and February 6, 2023, contingent on continued service to the company. F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2020. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:03 UTC |
Halpin MichaelChief Operating Officer
|
SaleCommon Stock | 2,890 | $15.00 | $43,350.00 |
DisclosureSEC source: 0001593968-20-001498 · primary_01.xml · nonDerivative · entry 2 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,734 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2020. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:03 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionCommon Stock | 2,890 | $2.65 | $7,658.50 |
DisclosureSEC source: 0001593968-20-001498 · primary_01.xml · nonDerivative · entry 1 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 08, 2020 Filed May 8, 2020 20:09 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001593968-20-001133 · primary_01.xml · derivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,625 Underlying: Common Stock · 13,125 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase a total of 210,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted. Read SEC document |
| May 08, 2020 Filed May 8, 2020 20:09 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 13,125 | $2.75 | $36,093.75 |
DisclosureSEC source: 0001593968-20-001133 · primary_01.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:15 UTC |
GILMAN STEVEN CDirector
|
GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001089 · primary_01.xml · derivative · entry 4 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F6 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 29, 2021 or the date of the first Annual Meeting of Stockholders following April 29, 2020. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:15 UTC |
GILMAN STEVEN CDirector
|
GrantStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $14.56 | $0.00 |
DisclosureSEC source: 0001593968-20-001089 · primary_01.xml · derivative · entry 3 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2030-04-29 F5 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:15 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | $14.56 | $25,480.00 |
DisclosureSEC source: 0001593968-20-001089 · primary_01.xml · derivative · entry 2 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. The first Annual Meeting of Stockholders occurred on April 29, 2020. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:15 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001089 · primary_01.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units granted to the Reporting Person on May 1, 2019. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:17 UTC |
ZERBE ROBERT L MDDirector
|
GrantStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $14.56 | $0.00 |
DisclosureSEC source: 0001593968-20-001090 · primary_01.xml · derivative · entry 4 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2030-04-29 F6 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:17 UTC |
ZERBE ROBERT L MDDirector
|
GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001090 · primary_01.xml · derivative · entry 3 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F5 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 29, 2021 or the date of the first Annual Meeting of Stockholders following April 29, 2020. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:17 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001090 · primary_01.xml · derivative · entry 2 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. The first Annual Meeting of Stockholders occurred on April 29, 2020. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:17 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001090 · primary_01.xml · nonDerivative · entry 1 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units granted to the Reporting Person on May 1, 2019. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:14 UTC |
Hagen HeidiDirector
|
GrantStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $14.56 | $0.00 |
DisclosureSEC source: 0001593968-20-001088 · primary_01.xml · derivative · entry 4 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2030-04-29 F6 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:14 UTC |
Hagen HeidiDirector
|
GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001088 · primary_01.xml · derivative · entry 3 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F5 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 29, 2021 or the date of the first Annual Meeting of Stockholders following April 29, 2020. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:14 UTC |
Hagen HeidiDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | $14.56 | $25,480.00 |
DisclosureSEC source: 0001593968-20-001088 · primary_01.xml · derivative · entry 2 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. The first Annual Meeting of Stockholders occurred on April 29, 2020. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:14 UTC |
Hagen HeidiDirector
|
Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001088 · primary_01.xml · nonDerivative · entry 1 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units granted to the Reporting Person on May 1, 2019. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:13 UTC |
MCLAUGHLIN KEVIN FDirector
|
GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001087 · primary_01.xml · derivative · entry 4 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F6 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 29, 2021 or the date of the first Annual Meeting of Stockholders following April 29, 2020. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:13 UTC |
MCLAUGHLIN KEVIN FDirector
|
GrantStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $14.56 | $0.00 |
DisclosureSEC source: 0001593968-20-001087 · primary_01.xml · derivative · entry 3 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2030-04-29 F5 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:13 UTC |
MCLAUGHLIN KEVIN FDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | $14.56 | $25,480.00 |
DisclosureSEC source: 0001593968-20-001087 · primary_01.xml · derivative · entry 2 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. The first Annual Meeting of Stockholders occurred on April 29, 2020. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:13 UTC |
MCLAUGHLIN KEVIN FDirector
|
Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001087 · primary_01.xml · nonDerivative · entry 1 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units granted to the Reporting Person on May 1, 2019. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:12 UTC |
Wotton Paul KDirector
|
GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001086 · primary_01.xml · derivative · entry 4 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F6 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 29, 2021 or the date of the first Annual Meeting of Stockholders following April 29, 2020. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:12 UTC |
Wotton Paul KDirector
|
GrantStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $14.56 | $0.00 |
DisclosureSEC source: 0001593968-20-001086 · primary_01.xml · derivative · entry 3 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2030-04-29 F5 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:12 UTC |
Wotton Paul KDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | $14.56 | $25,480.00 |
DisclosureSEC source: 0001593968-20-001086 · primary_01.xml · derivative · entry 2 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. The first Annual Meeting of Stockholders occurred on April 29, 2020. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:12 UTC |
Wotton Paul KDirector
|
Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001086 · primary_01.xml · nonDerivative · entry 1 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units granted to the Reporting Person on May 1, 2019. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:09 UTC |
Rubino Alan LDirector
|
GrantStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $14.56 | $0.00 |
DisclosureSEC source: 0001593968-20-001085 · primary_01.xml · derivative · entry 5 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2030-04-29 F6 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:09 UTC |
Rubino Alan LDirector
|
GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001085 · primary_01.xml · derivative · entry 4 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F5 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 29, 2021 or the date of the first Annual Meeting of Stockholders following April 29, 2020. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:09 UTC |
Rubino Alan LDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | $14.56 | $25,480.00 |
DisclosureSEC source: 0001593968-20-001085 · primary_01.xml · derivative · entry 3 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. The first Annual Meeting of Stockholders occurred on April 29, 2020. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:09 UTC |
Rubino Alan LDirector
|
Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001085 · primary_01.xml · nonDerivative · entry 1 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units granted to the Reporting Person on May 1, 2019. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,625 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · derivative · entry 14 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 5,625 shares Expires 2027-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 6.25% of these options, representing the right to purchase a total of 30,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continue to vest in equal quarterly installments from August 8, 2017, contingent upon the continued service to the Company. F8 · balance_after: These transaction relate to the 30,000 stock options granted to Mr. Michel on May 22, 2017. The remaining beneficially owned stock option (right to buy) after both transactions is 7,500. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,673 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · derivative · entry 13 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 7,673 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase a total of 70,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted. F4 · balance_after: These transactions relate to the 70,000 stock options granted to Mr. Michel on February 8, 2017. The remaining beneficially owned stock option (right to buy) after both transactions is 17,500. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,875 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · derivative · entry 12 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 1,875 shares Expires 2027-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 6.25% of these options, representing the right to purchase a total of 30,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continue to vest in equal quarterly installments from August 8, 2017, contingent upon the continued service to the Company. F8 · balance_after: These transaction relate to the 30,000 stock options granted to Mr. Michel on May 22, 2017. The remaining beneficially owned stock option (right to buy) after both transactions is 7,500. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,090 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · derivative · entry 11 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,035 Underlying: Common Stock · 3,090 shares Expires 2028-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options, representing the right to purchase a total of 100,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 7, 2018, which was one quarter after the date on which the option was granted. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 58,519 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · derivative · entry 10 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,519 shares Expires 2025-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options, representing the right to purchase a total of 180,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,375 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · derivative · entry 9 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,173 Underlying: Common Stock · 4,375 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase a total of 70,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted. F4 · balance_after: These transactions relate to the 70,000 stock options granted to Mr. Michel on February 8, 2017. The remaining beneficially owned stock option (right to buy) after both transactions is 17,500. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · derivative · entry 8 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2026-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 80,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 5,625 | $2.65 | $14,906.25 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · nonDerivative · entry 7 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 7,673 | $2.75 | $21,100.75 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · nonDerivative · entry 6 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 1,875 | $2.65 | $4,968.75 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · nonDerivative · entry 5 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 3,090 | $7.20 | $22,248.00 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · nonDerivative · entry 4 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 4,375 | $2.75 | $12,031.25 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · nonDerivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.